William B. Campbell

Characterization of 14,15-Epoxyeicosatrienoyl-Sulfonamides as 14,15-Epoxyeicosatrienoic Acid Agonists: Use for Studies of Metabolism and Ligand Binding

J. Falck, W. Campbell, Xiu-Yu Yi, 2007, Journal of Pharmacology and Experimental Therapeutics.

Endothelium-derived hyperpolarizing factors and vascular cytochrome P450 metabolites of arachidonic acid in the regulation of tone.

W. Campbell, D. Harder, William B. Campbell, 1999, Circulation research.

14,15-Epoxyeicosa-5(Z)-enoic Acid: A Selective Epoxyeicosatrienoic Acid Antagonist That Inhibits Endothelium-Dependent Hyperpolarization and Relaxation in Coronary Arteries

J. Falck, W. Campbell, K. Gauthier, 2002, Circulation research.

25-hydroxycholesterol increases eicosanoids and alters morphology in cultured pulmonary artery smooth muscle and endothelial cells.

W. Campbell, E. Wohlfeil, William B. Campbell, 1999, Arteriosclerosis, thrombosis, and vascular biology.

Human platelets and polymorphonuclear leukocytes synthesize oxygenated derivatives of arachidonylethanolamide (anandamide): their affinities for cannabinoid receptors and pathways of inactivation.

J. Falck, W. Campbell, C. Hillard, 1998, Molecular pharmacology.

Characterization of the kinetics and distribution of N-arachidonylethanolamine (anandamide) hydrolysis by rat brain.

W. Campbell, C. Hillard, W. Edgemond, 1995, Biochimica et biophysica acta.

Comparison of vasodilatory properties of 14,15-EET analogs: structural requirements for dilation.

J. Falck, W. Campbell, K. Reddy, 2003, American journal of physiology. Heart and circulatory physiology.